Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.48%
- Poor long term growth as Net Sales has grown by an annual rate of -12.46% and Operating profit at 17.16% over the last 5 years
- The company is Net-Debt Free
2
Negative results in Mar 26
3
With ROE of 17.10%, it has a very expensive valuation with a 12.19 Price to Book Value
4
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-22.66%
0%
-22.66%
6 Months
-26.12%
0%
-26.12%
1 Year
-22.86%
0%
-22.86%
2 Years
22.73%
0%
22.73%
3 Years
-12.65%
0%
-12.65%
4 Years
-13.41%
0%
-13.41%
5 Years
-41.99%
0%
-41.99%
Jiangsu Aoyang Health Industry Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-12.46%
EBIT Growth (5y)
17.16%
EBIT to Interest (avg)
-1.32
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
4.28
Sales to Capital Employed (avg)
1.56
Tax Ratio
41.88%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.48%
ROE (avg)
10.97%
Valuation key factors
Factor
Value
P/E Ratio
71
Industry P/E
Price to Book Value
12.19
EV to EBIT
40.75
EV to EBITDA
24.18
EV to Capital Employed
3.52
EV to Sales
1.61
PEG Ratio
10.27
Dividend Yield
NA
ROCE (Latest)
8.63%
ROE (Latest)
17.10%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
406.70
446.40
-8.89%
Operating Profit (PBDIT) excl Other Income
16.30
18.70
-12.83%
Interest
8.30
6.20
33.87%
Exceptional Items
0.00
-2.70
100.00%
Consolidate Net Profit
5.20
1.20
333.33%
Operating Profit Margin (Excl OI)
40.10%
6.70%
3.34%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -8.89% vs -2.45% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 333.33% vs -86.21% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,805.40
2,008.30
-10.10%
Operating Profit (PBDIT) excl Other Income
148.00
157.60
-6.09%
Interest
39.20
54.20
-27.68%
Exceptional Items
-2.90
-0.20
-1,350.00%
Consolidate Net Profit
41.90
41.20
1.70%
Operating Profit Margin (Excl OI)
46.60%
44.00%
0.26%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -10.10% vs -7.14% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 1.70% vs -18.09% in Dec 2024
About Jiangsu Aoyang Health Industry Co., Ltd. 
Jiangsu Aoyang Health Industry Co., Ltd.
Garments & Apparels
No Details Available.
Company Coordinates 
No Company Details Available






